» Authors » Gabriela Godaly

Gabriela Godaly

Explore the profile of Gabriela Godaly including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 449
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ambite I, Chao S, Rosenblad T, Hopkins R, Storm P, Ng Y, et al.
Life Sci Alliance . 2025 Mar; 8(3). PMID: 40036168
This study investigated the molecular basis of disease severity in acute pyelonephritis (APN), a common and potentially life-threatening bacterial infection. Two cohorts of infants with febrile urinary tract infection were...
2.
Davids C, Umashankar-Rao K, Kassaliete J, Ahmadi S, Happonen L, Welinder C, et al.
Sci Rep . 2024 Nov; 14(1):28198. PMID: 39548211
Pulmonary tuberculosis (TB) causes progressive and irreversible damage to lung tissue, a damage that may not fully resolve after treatment. Mycobacterial vesicles (MVs), which are poorly understood, may contribute to...
3.
Rosenblad T, Linden M, Ambite I, Brandstrom P, Hansson S, Godaly G
Pediatr Nephrol . 2024 May; 39(9):2703-2715. PMID: 38767678
Background: Febrile urinary tract infections (UTIs) are among the most severe bacterial infections in infants, in which a subset of patients develops complications. Identifying infants at risk of recurrent infections...
4.
Campos Pacheco J, Yalovenko T, Riaz A, Kotov N, Davids C, Persson A, et al.
J Control Release . 2024 Mar; 369:231-250. PMID: 38479444
Inhalation therapy treating severe infectious disease is among the more complex and emerging topics in controlled drug release. Micron-sized carriers are needed to deposit drugs into the lower airways, while...
5.
Rao K, Godaly G
Methods Mol Biol . 2023 May; 2674:55-60. PMID: 37258959
Bacterial extracellular vesicles (EVs) contain numerous active substances that mediate bacterial interactions with their host and with other microbes. Best defined are the EVs from Gram-negative bacteria that have been...
6.
Rao K, Li P, Welinder C, Tenland E, Gourdon P, Sturegard E, et al.
Pharmaceutics . 2023 Feb; 15(2). PMID: 36839864
Multidrug-resistant tuberculosis (MDR) continues to pose a threat to public health. Previously, we identified a cationic host defense peptide with activity against in vivo and with a bactericidal effect against...
7.
Gronberg C, Hu Q, Ram Mahato D, Longhin E, Salustros N, Duelli A, et al.
Elife . 2021 Dec; 10. PMID: 34951590
Transition metals, such as zinc, are essential micronutrients in all organisms, but also highly toxic in excessive amounts. Heavy-metal transporting P-type (P) ATPases are crucial for homeostasis, conferring cellular detoxification...
8.
Rao K, Henderson D, Krishnan N, Puthia M, Glegola-Madejska I, Brive L, et al.
Sci Rep . 2021 Feb; 11(1):4201. PMID: 33603037
Alternative ways to prevent and treat infectious diseases are needed. Previously, we identified a fungal peptide, NZX, that was comparable to rifampicin in lowering M. tuberculosis load in a murine...
9.
Alaridah N, Tang Hallback E, Tangrot J, Winqvist N, Sturegard E, Floren-Johansson K, et al.
Sci Rep . 2019 Mar; 9(1):4931. PMID: 30894568
Epidemiological contact tracing complemented with genotyping of clinical Mycobacterium tuberculosis isolates is important for understanding disease transmission. In Sweden, tuberculosis (TB) is mostly reported in migrant and homeless where epidemiologic...
10.
Tenland E, Pochert A, Krishnan N, Rao K, Kalsum S, Braun K, et al.
PLoS One . 2019 Feb; 14(2):e0212858. PMID: 30807612
Background: Intracellular delivery of antimicrobial agents by nanoparticles, such as mesoporous silica particles (MSPs), offers an interesting strategy to treat intracellular infections. In tuberculosis (TB), Mycobacterium tuberculosis avoids components of...